Chengyi Zheng

Kaiser Permanente

Papers

1

Total Citations

30

H-Index

1

About

Chengyi Zheng is a health outcomes researcher whose work centers on patient-reported outcomes and health-related quality of life (HRQoL) in oncology, with a particular focus on prostate cancer. His major contribution lies in leveraging large, diverse, real-world patient populations to assess how different treatments affect patients' well-being over time. His most-cited paper, "Health-related quality of life outcomes from a contemporary prostate cancer registry in a large diverse population" (2017, 30 citations), provides critical insights into HRQoL trajectories up to 24 months post-treatment, using data from a contemporary registry within a large healthcare system. This work is notable for its emphasis on diversity and real-world applicability, helping clinicians and patients make more informed treatment decisions. By bridging clinical outcomes with patient perspectives, Zheng’s research has influenced how prostate cancer care is evaluated beyond traditional metrics, underscoring the importance of quality of life in treatment planning. His findings continue to guide evidence-based practice in urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
30
Total Citations
30
Avg Citations/Paper
🏆 Most Cited Paper
Health‐related quality of life outcomes from a contemporary prostate cancer registry in a large diverse population
30 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Kaiser Permanente

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago